Profile
Matthew Foster is currently the Chief Restructuring Officer at Allena Pharmaceuticals, Inc. since 2022.
Prior to this, he held the position of Chief Restructuring Officer at Argos Therapeutics, Inc.
Matthew Foster active positions
| Companies | Position | Start |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-09-01 |
Former positions of Matthew Foster
| Companies | Position | End |
|---|---|---|
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ALLENA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
- Stock Market
- Insiders
- Matthew Foster
